수의학 임상 의사결정 지원 시장 예측(-2034년) : 솔루션 유형, 도입 형태, 대상 동물, 기술, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Veterinary Clinical Decision Support Market is accounted for $0.5 billion in 2026 and is expected to reach $1.6 billion by 2034 growing at a CAGR of 15.6% during the forecast period. Veterinary Clinical Decision Support refers to the use of digital technologies, evidence-based knowledge systems, artificial intelligence, and analytical tools to assist veterinary professionals in clinical decision-making throughout the diagnostic and treatment process. It integrates patient information, medical guidelines, diagnostic results, and clinical data to generate relevant recommendations, alerts, and insights. By supporting accurate diagnosis, treatment planning, medication management, and preventive care, veterinary clinical decision support enhances clinical consistency, improves patient outcomes, and promotes informed veterinary practice.

Market Dynamics:

Driver:

Diagnostic complexity increases

The expanding complexity of veterinary diagnostics is driving substantial demand for clinical decision support systems that augment practitioner expertise. Advances in molecular diagnostics, advanced imaging, and laboratory testing generate vast amounts of data that exceed human cognitive processing capacity. Artificial intelligence algorithms identify patterns in laboratory results, radiographs, and clinical histories that support accurate differential diagnosis. End-user veterinarians report improved confidence in complex cases when supported by evidence-based recommendation engines. The integration of genomic and biomarker data into routine diagnostics further amplifies the need for intelligent decision support tools.

Restraint:

Adoption resistance

The traditional culture of veterinary medicine emphasizes hands-on clinical judgment that some practitioners view as threatened by algorithmic decision support. Experienced veterinarians may perceive artificial intelligence recommendations as undermining their professional expertise and autonomy. Concerns regarding liability when following versus overriding system recommendations create legal uncertainty. The time required to learn new interfaces and integrate support tools into established workflows discourages busy practitioners. These cultural and practical barriers necessitate careful change management and demonstration of tangible clinical benefits.

Opportunity:

Telemedicine enablement

The rapid growth of veterinary telemedicine presents transformative market expansion opportunities for clinical decision support platforms. Remote consultations lack physical examination capabilities, making structured decision support essential for safe and effective care delivery. Automated triage algorithms help telemedicine providers assess case urgency and recommend appropriate care pathways. The technology enables veterinary paraprofessionals and nurse helplines to provide consistent, evidence-based advice under clinical decision support guidance. Partnerships between telemedicine platforms and decision support vendors create integrated virtual care ecosystems.

Threat:

Data quality limitations

The quality and completeness of veterinary clinical data threaten the reliability of artificial intelligence-driven decision support systems. Inconsistent medical record documentation, incomplete patient histories, and variable diagnostic testing practices introduce noise that degrades algorithm performance. The relative scarcity of large, labeled veterinary datasets compared to human medicine limits model training and validation. Species-specific physiological variations complicate cross-species algorithm generalization. These data challenges necessitate substantial investment in curated datasets and continuous model refinement.

Covid-19 Impact:

The COVID-19 pandemic accelerated veterinary telemedicine adoption, creating immediate demand for clinical decision support tools that enable remote care delivery. Lockdown measures restricted physical clinic access, prompting veterinarians to rely on structured decision frameworks for virtual consultations. However, reduced elective veterinary visits temporarily decreased overall diagnostic testing volumes. Post-pandemic, the normalization of hybrid care models and continued telemedicine growth support sustained investment in clinical decision support infrastructure.

The diagnostic decision support systems segment is expected to be the largest during the forecast period

The Diagnostic Decision Support Systems segment is expected to account for the largest market share during the forecast period, due to the critical importance of accurate diagnosis as the foundation of effective veterinary treatment. These systems analyze clinical signs, laboratory results, imaging findings, and patient history to generate ranked differential diagnoses with associated probabilities. The platforms integrate extensive veterinary medical knowledge bases covering multiple species and specialties. The growing complexity of diagnostic testing panels creates demand for intelligent interpretation assistance. Major veterinary diagnostic companies embed decision support capabilities into laboratory reporting systems.

The cloud-based segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cloud-based segment is predicted to witness the highest growth rate, driven by increasing demand for centralized clinical data management, real-time decision support, and scalable veterinary software solutions. Growing adoption of cloud-enabled electronic medical records, AI-powered diagnostic assistance, and remote collaboration platforms is accelerating market expansion. Enhanced accessibility, seamless software updates, lower infrastructure costs, and secure data sharing across veterinary networks further strengthen adoption, positioning cloud-based deployment as the fastest-growing segment in the Veterinary Clinical Decision Support Market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to advanced veterinary specialty infrastructure and early adoption of artificial intelligence technologies. The United States leads with extensive networks of veterinary specialty hospitals and academic institutions that generate the clinical data required for algorithm development. Canada contributes through its progressive veterinary technology adoption and well-funded research programs. High pet ownership rates and willingness to invest in advanced diagnostics drive demand for decision support tools. Major companies, including IDEXX Laboratories, Zoetis, and Mars Science & Diagnostics, maintain substantial market presence across the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly expanding veterinary services and increasing investment in digital health technologies. China and India represent major growth markets with growing pet populations and the modernization of veterinary education. Japan and South Korea demonstrate high technology adoption rates and advanced veterinary diagnostic capabilities. Growing awareness of artificial intelligence applications in healthcare extends to veterinary medicine. The region's expanding technology sector provides indigenous software development and machine learning expertise.

Key players in the market

Some of the key players in Veterinary Clinical Decision Support Market include IDEXX Laboratories, Inc., Covetrus, Inc., Zoetis Inc., ezyVet Limited, Merck Animal Health, Boehringer Ingelheim Animal Health, Vetology Innovations, SignalPET, Antech Diagnostics, Mars Science & Diagnostics, Ceva Sante Animale, Virbac S.A., Dechra Pharmaceuticals PLC, Heska Corporation, Animal Intelligence Software Inc., VetCT and Imaginalis.

Key Developments:

In June 2026, Antech Diagnostics launched an artificial intelligence-powered radiograph interpretation platform achieving specialist-level diagnostic accuracy across canine and feline musculoskeletal conditions.

In May 2026, Merck Animal Health secured a major contract deploying clinical decision support systems across European veterinary hospital networks for standardized diagnostic protocols and treatment recommendations.

In April 2026, ezyVet Limited introduced a next-generation natural language processing tool for automated clinical documentation and voice-activated diagnostic query assistance in busy veterinary practices.

Solution Types Covered:

• Diagnostic Decision Support Systems
• Treatment Planning Software
• Drug Interaction Databases
• Clinical Knowledge Management Platforms
• Imaging Decision Support Solutions
• AI-Based Diagnostic Assistants
• Evidence-Based Clinical Support Systems

Deployment Modes Covered:

• Cloud-Based
• On-Premises
• Hybrid Deployment
• Web-Based Platforms

Animal Types Covered:

• Companion Animals
• Livestock
• Equine
• Exotic Animals
• Aquatic Animals
• Wildlife

Technologies Covered:

• Artificial Intelligence
• Machine Learning
• Natural Language Processing
• Big Data Analytics
• Clinical Knowledge Graphs
• Cloud Computing

Applications Covered:

• Disease Diagnosis
• Treatment Recommendations
• Clinical Documentation
• Medication Management
• Diagnostic Imaging
• Preventive Care Planning

End Users Covered:

• Veterinary Hospitals
• Veterinary Clinics
• Academic Institutions
• Diagnostic Laboratories
• Research Organizations
• Telemedicine Providers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Clinical Decision Support Market, By Solution Type

• 5.1 Diagnostic Decision Support Systems
• 5.2 Treatment Planning Software
• 5.3 Drug Interaction Databases
• 5.4 Clinical Knowledge Management Platforms
• 5.5 Imaging Decision Support Solutions
• 5.6 AI-Based Diagnostic Assistants
• 5.7 Evidence-Based Clinical Support Systems

6 Global Veterinary Clinical Decision Support Market, By Deployment Mode

• 6.1 Cloud-Based
• 6.2 On-Premises
• 6.3 Hybrid Deployment
• 6.4 Web-Based Platforms

7 Global Veterinary Clinical Decision Support Market, By Animal Type

• 7.1 Companion Animals
• 7.2 Livestock
• 7.3 Equine
• 7.4 Exotic Animals
• 7.5 Aquatic Animals
• 7.6 Wildlife

8 Global Veterinary Clinical Decision Support Market, By Technology

• 8.1 Artificial Intelligence
• 8.2 Machine Learning
• 8.3 Natural Language Processing
• 8.4 Big Data Analytics
• 8.5 Clinical Knowledge Graphs
• 8.6 Cloud Computing

9 Global Veterinary Clinical Decision Support Market, By Application

• 9.1 Disease Diagnosis
• 9.2 Treatment Recommendations
• 9.3 Clinical Documentation
• 9.4 Medication Management
• 9.5 Diagnostic Imaging
• 9.6 Preventive Care Planning

10 Global Veterinary Clinical Decision Support Market, By End User

• 10.1 Veterinary Hospitals
• 10.2 Veterinary Clinics
• 10.3 Academic Institutions
• 10.4 Diagnostic Laboratories
• 10.5 Research Organizations
• 10.6 Telemedicine Providers

11 Global Veterinary Clinical Decision Support Market, By Geography

• 11.1 North America
  • 11.1.1 United States
  • 11.1.2 Canada
  • 11.1.3 Mexico
• 11.2 Europe
  • 11.2.1 United Kingdom
  • 11.2.2 Germany
  • 11.2.3 France
  • 11.2.4 Italy
  • 11.2.5 Spain
  • 11.2.6 Netherlands
  • 11.2.7 Belgium
  • 11.2.8 Sweden
  • 11.2.9 Switzerland
  • 11.2.10 Poland
  • 11.2.11 Rest of Europe
• 11.3 Asia Pacific
  • 11.3.1 China
  • 11.3.2 Japan
  • 11.3.3 India
  • 11.3.4 South Korea
  • 11.3.5 Australia
  • 11.3.6 Indonesia
  • 11.3.7 Thailand
  • 11.3.8 Malaysia
  • 11.3.9 Singapore
  • 11.3.10 Vietnam
  • 11.3.11 Rest of Asia Pacific
• 11.4 South America
  • 11.4.1 Brazil
  • 11.4.2 Argentina
  • 11.4.3 Colombia
  • 11.4.4 Chile
  • 11.4.5 Peru
  • 11.4.6 Rest of South America
• 11.5 Rest of the World (RoW)
  • 11.5.1 Middle East
    • 11.5.1.1 Saudi Arabia
    • 11.5.1.2 United Arab Emirates
    • 11.5.1.3 Qatar
    • 11.5.1.4 Israel
    • 11.5.1.5 Rest of Middle East
  • 11.5.2 Africa
    • 11.5.2.1 South Africa
    • 11.5.2.2 Egypt
    • 11.5.2.3 Morocco
    • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

• 12.1 Industry Value Network and Supply Chain Assessment
• 12.2 White-Space and Opportunity Mapping
• 12.3 Product Evolution and Market Life Cycle Analysis
• 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

• 13.1 Mergers and Acquisitions
• 13.2 Partnerships, Alliances, and Joint Ventures
• 13.3 New Product Launches and Certifications
• 13.4 Capacity Expansion and Investments
• 13.5 Other Strategic Initiatives

14 Company Profiles

• 14.1 IDEXX Laboratories, Inc.
• 14.2 Covetrus, Inc.
• 14.3 Zoetis Inc.
• 14.4 ezyVet Limited
• 14.5 Merck Animal Health
• 14.6 Boehringer Ingelheim Animal Health
• 14.7 Vetology Innovations
• 14.8 SignalPET
• 14.9 Antech Diagnostics
• 14.10 Mars Science & Diagnostics
• 14.11 Ceva Sante Animale
• 14.12 Virbac S.A.
• 14.13 Dechra Pharmaceuticals PLC
• 14.14 Heska Corporation
• 14.15 Animal Intelligence Software Inc.
• 14.16 VetCT
• 14.17 Imaginalis